What is the current Price Target for the Amylyx Pharmaceuticals stock?

The average Amylyx Pharmaceuticals target price is $19.38. This is 57.18% higher than the current stock price. The highest price target is 112.90%, the lowest is -18.09%. 11 Analysts have issued a price target Amylyx Pharmaceuticals 2026 .

How high will the Amylyx Pharmaceuticals stock rise?

No reliable answer can be given as to how high the Amylyx Pharmaceuticals stock will rise. The performance of stocks, including the Amylyx Pharmaceuticals stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Amylyx Pharmaceuticals stock today?

The performance of Amylyx Pharmaceuticals stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Amylyx Pharmaceuticals stock fall?

The decline in Amylyx Pharmaceuticals stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Amylyx Pharmaceuticals Forecast, price target & analysts

$12.33

2.76% yesterday

NYSE, Nov 12, 10:00 pm CET

ISIN

US03237H1014

Symbol

AMLX

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Amylyx Pharmaceuticals Target price 2025 - Analyst rating & recommendation

Amylyx Pharmaceuticals Classifications & Recommendation:

Buy

88%

Hold

12%

Amylyx Pharmaceuticals Price Target

Target Price	$19.38
Price	$12.33
Potential	57.18% register free of charge
Number of Estimates	11

	11 Analysts have issued a price target Amylyx Pharmaceuticals 2026 . The average Amylyx Pharmaceuticals target price is $19.38. This is 57.18% register free of charge higher than the current stock price. The highest price target is $26.25 112.90% register free of charge , the lowest is $10.10 18.09% register free of charge .
	A rating was issued by 17 analysts: 15 Analysts recommend Amylyx Pharmaceuticals to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Amylyx Pharmaceuticals stock has an average upside potential 2026 of 57.18% register free of charge . Most analysts recommend the Amylyx Pharmaceuticals stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-4.43	-1.72
	732.86%	61.17%
P/E		negative

12 Analysts have issued a Amylyx Pharmaceuticals forecast for earnings per share. The average Amylyx Pharmaceuticals EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-4.43	732.86%
2025	$-1.72 61.17% Unlock
2026	$-1.49 13.37% Unlock
2027	$-1.56 4.70% Unlock
2028	$-1.01 35.26% Unlock
2029	$-0.06 94.06% Unlock
2030	$1.33 2,316.67% Unlock
2031	$2.16 62.41% Unlock
2032	$2.92 35.19% Unlock

Current	-7.75	342.14%
2025	-7.19 7.28% Unlock
2026	-8.29 15.30% Unlock
2027	-7.89 4.83% Unlock
2028	-12.15 53.99% Unlock
2029	-201.47 1,558.19% Unlock
2030	9.25 104.59% Unlock
2031	5.70 38.38% Unlock
2032	4.22 25.96% Unlock

Amylyx Pharmaceuticals...

Current Amylyx Pharmaceuticals Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 07 2025
Citigroup	Locked ➜ Locked	Locked	Oct 17 2025
Baird	Locked ➜ Locked	Locked	Oct 16 2025
B of A Securities	Locked ➜ Locked	Locked	Oct 03 2025
Goldman Sachs	Locked ➜ Locked	Locked	Sep 16 2025
Guggenheim	Locked ➜ Locked	Locked	Sep 15 2025
B of A Securities	Locked ➜ Locked	Locked	Aug 28 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 07 2025
Locked Citigroup: Locked ➜ Locked	Oct 17 2025
Locked Baird: Locked ➜ Locked	Oct 16 2025
Locked B of A Securities: Locked ➜ Locked	Oct 03 2025
Locked Goldman Sachs: Locked ➜ Locked	Sep 16 2025
Locked Guggenheim: Locked ➜ Locked	Sep 15 2025
Locked B of A Securities: Locked ➜ Locked	Aug 28 2025

Discover more stocks with a high price target

TUI 46.74%

Meta Platforms (Facebook) 46.55%

Adidas 46.38%

Novo Nordisk 45.35%

Deutsche Telekom 41.93%

Coinbase Global, Inc. 35.55%

BioNTech SE - ADR 24.65%

Linde 23.17%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now